GrayBella Capital (GBC) is a pan-European VC Fund based in London. GBC specializes in high-growth deep-tech and health-tech companies across the UK and Europe. We invest at Series A and beyond, backing transformative innovations in AI, material science, robotics, medical devices, digital health, AI, diagnostics, and healthcare platforms. We only invest in B2B. We do not invest in consumer tech or therapeutics. We typically serve as a Lead or co-Lead.